InVivoMab anti-mouse CD86 (B7-2) BE0025-R001mg from Bio X Cell | Biocompare.com

Supplier Images

InVivoMab anti-mouse CD86 (B7-2)

Be the first to write a review!

Citations:

Supplier Page from
Bio X Cell for
InVivoMab anti-mouse CD86 (B7-2)

The InVivoMab anti-mouse CD86 (B7-2) Antibody from Bio X Cell is a Rat Monoclonal antibody to CD86. This antibody recognizes Mouse antigen. The InVivoMab anti-mouse CD86 (B7-2) Antibody has been validated for the following applications: In Vivo, Block/Neutralize/Inhibit, and Flow Cytometry.

Description

Bio X Cell InVivoMAb anti-mouse CD86 (B7-2) Monoclonal Antibody has the following reported applications: in vivo CD86 blockade, Flow cytometry. It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMab anti-mouse CD86 (B7-2)
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0025-R001mg
Quantity1 mg
ApplicationsIn vivo CD86 blockade, Flow cytometry
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetCD86
IsotypeIgG2a, κ
CloneGL-1
Hostrat
NCBI Full Gene NameCD86 antigen
NCBI Gene AliasesB7, B7-2, B7.2, B70, CLS1, Cd28l2, ETC-1, Ly-58, Ly58, MB7, MB7-2, TS/A-2
ClonalityMonoclonal
ImmunogenLPS-activated CBA/Ca mouse splenic B cells
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCancer Biology, Immune Checkpoint Protein, Immunology

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cellsJournal of immunology (Baltimore, Md. : 1950)December 1, 2014Marshall D, Sinclair C, Tung S, Seddon B.

(2) Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent mannerPLoS pathogensAugust 1, 2014Moser EK, Hufford MM, Braciale TJ.

(3) Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infectionThe Journal of experimental medicineMay 5, 2014Srivastava S, Koch MA, Pepper M, Campbell DJ.

(4) Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivoJournal of immunology (Baltimore, Md. : 1950)June 1, 2012Arjunaraja S, Paoletti LC, Snapper CM.

(5) Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restrictionJournal of immunology (Baltimore, Md. : 1950)September 15, 2011Kastenmuller W, Gasteiger G, Subramanian N, Sparwasser T, Busch DH, Belkaid Y, Drexler I, Germain RN.

Be the First to Write a Review!